nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupropion—CYP2A6—Fluorouracil—head and neck cancer	0.188	0.272	CbGbCtD
Bupropion—CYP2D6—Hydroxyurea—head and neck cancer	0.154	0.224	CbGbCtD
Bupropion—CYP2C8—Fluorouracil—head and neck cancer	0.0925	0.134	CbGbCtD
Bupropion—CYP1A2—Fluorouracil—head and neck cancer	0.0716	0.104	CbGbCtD
Bupropion—CYP2C9—Fluorouracil—head and neck cancer	0.0645	0.0937	CbGbCtD
Bupropion—CYP2D6—Vinblastine—head and neck cancer	0.0546	0.0794	CbGbCtD
Bupropion—CYP3A4—Vinblastine—head and neck cancer	0.0347	0.0505	CbGbCtD
Bupropion—CYP3A4—Docetaxel—head and neck cancer	0.0286	0.0416	CbGbCtD
Bupropion—Hypoaesthesia—Vinblastine—head and neck cancer	0.00105	0.00406	CcSEcCtD
Bupropion—Pharyngitis—Vinblastine—head and neck cancer	0.00105	0.00404	CcSEcCtD
Bupropion—Hearing impaired—Docetaxel—head and neck cancer	0.00104	0.00404	CcSEcCtD
Bupropion—Stomatitis—Hydroxyurea—head and neck cancer	0.00104	0.00404	CcSEcCtD
Bupropion—Lethargy—Fluorouracil—head and neck cancer	0.00102	0.00395	CcSEcCtD
Bupropion—Osteoarthritis—Fluorouracil—head and neck cancer	0.001	0.00387	CcSEcCtD
Bupropion—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.001	0.00387	CcSEcCtD
Bupropion—Blood pressure increased—Docetaxel—head and neck cancer	0.000995	0.00385	CcSEcCtD
Bupropion—Hepatocellular injury—Docetaxel—head and neck cancer	0.000995	0.00385	CcSEcCtD
Bupropion—Pulmonary embolism—Docetaxel—head and neck cancer	0.000995	0.00385	CcSEcCtD
Bupropion—Haemoglobin—Hydroxyurea—head and neck cancer	0.000966	0.00374	CcSEcCtD
Bupropion—Influenza like illness—Docetaxel—head and neck cancer	0.000966	0.00373	CcSEcCtD
Bupropion—Haemorrhage—Hydroxyurea—head and neck cancer	0.000961	0.00372	CcSEcCtD
Bupropion—Hallucination—Hydroxyurea—head and neck cancer	0.000956	0.0037	CcSEcCtD
Bupropion—Colitis—Docetaxel—head and neck cancer	0.000955	0.00369	CcSEcCtD
Bupropion—Irritability—Fluorouracil—head and neck cancer	0.000955	0.00369	CcSEcCtD
Bupropion—Ataxia—Fluorouracil—head and neck cancer	0.00094	0.00364	CcSEcCtD
Bupropion—Neuropathy—Docetaxel—head and neck cancer	0.000934	0.00361	CcSEcCtD
Bupropion—Alopecia—Vinblastine—head and neck cancer	0.000931	0.0036	CcSEcCtD
Bupropion—Dry skin—Fluorouracil—head and neck cancer	0.000917	0.00354	CcSEcCtD
Bupropion—Oesophagitis—Docetaxel—head and neck cancer	0.000909	0.00351	CcSEcCtD
Bupropion—Neoplasm—Docetaxel—head and neck cancer	0.000899	0.00348	CcSEcCtD
Bupropion—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000894	0.00346	CcSEcCtD
Bupropion—Muscular weakness—Fluorouracil—head and neck cancer	0.000882	0.00341	CcSEcCtD
Bupropion—Angiopathy—Hydroxyurea—head and neck cancer	0.000872	0.00337	CcSEcCtD
Bupropion—Dysphagia—Fluorouracil—head and neck cancer	0.000864	0.00334	CcSEcCtD
Bupropion—Chills—Hydroxyurea—head and neck cancer	0.000863	0.00333	CcSEcCtD
Bupropion—Ill-defined disorder—Vinblastine—head and neck cancer	0.000851	0.00329	CcSEcCtD
Bupropion—Alopecia—Hydroxyurea—head and neck cancer	0.000849	0.00328	CcSEcCtD
Bupropion—Anaemia—Vinblastine—head and neck cancer	0.000848	0.00328	CcSEcCtD
Bupropion—Phlebitis—Docetaxel—head and neck cancer	0.000838	0.00324	CcSEcCtD
Bupropion—Malaise—Vinblastine—head and neck cancer	0.000828	0.0032	CcSEcCtD
Bupropion—Vertigo—Vinblastine—head and neck cancer	0.000824	0.00319	CcSEcCtD
Bupropion—Leukopenia—Vinblastine—head and neck cancer	0.000821	0.00318	CcSEcCtD
Bupropion—Pancytopenia—Fluorouracil—head and neck cancer	0.000821	0.00317	CcSEcCtD
Bupropion—Deafness—Docetaxel—head and neck cancer	0.000807	0.00312	CcSEcCtD
Bupropion—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000803	0.00311	CcSEcCtD
Bupropion—Convulsion—Vinblastine—head and neck cancer	0.000795	0.00307	CcSEcCtD
Bupropion—Hypertension—Vinblastine—head and neck cancer	0.000792	0.00306	CcSEcCtD
Bupropion—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000789	0.00305	CcSEcCtD
Bupropion—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000776	0.003	CcSEcCtD
Bupropion—Pneumonia—Fluorouracil—head and neck cancer	0.000775	0.003	CcSEcCtD
Bupropion—Anaemia—Hydroxyurea—head and neck cancer	0.000773	0.00299	CcSEcCtD
Bupropion—Discomfort—Vinblastine—head and neck cancer	0.000772	0.00298	CcSEcCtD
Bupropion—Hot flush—Docetaxel—head and neck cancer	0.000772	0.00298	CcSEcCtD
Bupropion—Infestation—Fluorouracil—head and neck cancer	0.000771	0.00298	CcSEcCtD
Bupropion—Infestation NOS—Fluorouracil—head and neck cancer	0.000771	0.00298	CcSEcCtD
Bupropion—Menopausal symptoms—Docetaxel—head and neck cancer	0.000765	0.00296	CcSEcCtD
Bupropion—Visual disturbance—Docetaxel—head and neck cancer	0.000762	0.00295	CcSEcCtD
Bupropion—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00076	0.00294	CcSEcCtD
Bupropion—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000756	0.00292	CcSEcCtD
Bupropion—Myocardial infarction—Fluorouracil—head and neck cancer	0.000756	0.00292	CcSEcCtD
Bupropion—Malaise—Hydroxyurea—head and neck cancer	0.000755	0.00292	CcSEcCtD
Bupropion—Stomatitis—Fluorouracil—head and neck cancer	0.000751	0.0029	CcSEcCtD
Bupropion—Urinary tract infection—Fluorouracil—head and neck cancer	0.000749	0.0029	CcSEcCtD
Bupropion—Conjunctivitis—Fluorouracil—head and neck cancer	0.000749	0.0029	CcSEcCtD
Bupropion—Leukopenia—Hydroxyurea—head and neck cancer	0.000749	0.0029	CcSEcCtD
Bupropion—Lethargy—Docetaxel—head and neck cancer	0.000737	0.00285	CcSEcCtD
Bupropion—Thrombocytopenia—Vinblastine—head and neck cancer	0.000733	0.00284	CcSEcCtD
Bupropion—Epistaxis—Fluorouracil—head and neck cancer	0.000727	0.00281	CcSEcCtD
Bupropion—Convulsion—Hydroxyurea—head and neck cancer	0.000725	0.0028	CcSEcCtD
Bupropion—Sinusitis—Fluorouracil—head and neck cancer	0.000723	0.0028	CcSEcCtD
Bupropion—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000722	0.00279	CcSEcCtD
Bupropion—Pain in extremity—Docetaxel—head and neck cancer	0.000722	0.00279	CcSEcCtD
Bupropion—Anorexia—Vinblastine—head and neck cancer	0.000714	0.00276	CcSEcCtD
Bupropion—Migraine—Docetaxel—head and neck cancer	0.000711	0.00275	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000708	0.00274	CcSEcCtD
Bupropion—Discomfort—Hydroxyurea—head and neck cancer	0.000704	0.00272	CcSEcCtD
Bupropion—Haemoglobin—Fluorouracil—head and neck cancer	0.000695	0.00269	CcSEcCtD
Bupropion—Rhinitis—Fluorouracil—head and neck cancer	0.000694	0.00268	CcSEcCtD
Bupropion—Haemorrhage—Fluorouracil—head and neck cancer	0.000692	0.00268	CcSEcCtD
Bupropion—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000688	0.00266	CcSEcCtD
Bupropion—Pharyngitis—Fluorouracil—head and neck cancer	0.000687	0.00266	CcSEcCtD
Bupropion—Oedema—Hydroxyurea—head and neck cancer	0.000683	0.00264	CcSEcCtD
Bupropion—Ataxia—Docetaxel—head and neck cancer	0.000679	0.00262	CcSEcCtD
Bupropion—Infection—Hydroxyurea—head and neck cancer	0.000679	0.00262	CcSEcCtD
Bupropion—Paraesthesia—Vinblastine—head and neck cancer	0.000672	0.0026	CcSEcCtD
Bupropion—Dehydration—Docetaxel—head and neck cancer	0.000671	0.0026	CcSEcCtD
Bupropion—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00067	0.00259	CcSEcCtD
Bupropion—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000669	0.00259	CcSEcCtD
Bupropion—Skin disorder—Hydroxyurea—head and neck cancer	0.000663	0.00256	CcSEcCtD
Bupropion—Dry skin—Docetaxel—head and neck cancer	0.000662	0.00256	CcSEcCtD
Bupropion—Abdominal pain upper—Docetaxel—head and neck cancer	0.000659	0.00255	CcSEcCtD
Bupropion—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000659	0.00255	CcSEcCtD
Bupropion—Breast disorder—Docetaxel—head and neck cancer	0.000652	0.00252	CcSEcCtD
Bupropion—Anorexia—Hydroxyurea—head and neck cancer	0.000651	0.00252	CcSEcCtD
Bupropion—Decreased appetite—Vinblastine—head and neck cancer	0.000651	0.00252	CcSEcCtD
Bupropion—Cramp muscle—Docetaxel—head and neck cancer	0.00065	0.00251	CcSEcCtD
Bupropion—Nasopharyngitis—Docetaxel—head and neck cancer	0.000646	0.0025	CcSEcCtD
Bupropion—Constipation—Vinblastine—head and neck cancer	0.00064	0.00248	CcSEcCtD
Bupropion—Pain—Vinblastine—head and neck cancer	0.00064	0.00248	CcSEcCtD
Bupropion—Dysphagia—Docetaxel—head and neck cancer	0.000624	0.00241	CcSEcCtD
Bupropion—Arrhythmia—Fluorouracil—head and neck cancer	0.000618	0.00239	CcSEcCtD
Bupropion—Feeling abnormal—Vinblastine—head and neck cancer	0.000617	0.00239	CcSEcCtD
Bupropion—Bronchospasm—Docetaxel—head and neck cancer	0.000614	0.00237	CcSEcCtD
Bupropion—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000612	0.00237	CcSEcCtD
Bupropion—Alopecia—Fluorouracil—head and neck cancer	0.000611	0.00236	CcSEcCtD
Bupropion—Dyspnoea—Hydroxyurea—head and neck cancer	0.000609	0.00235	CcSEcCtD
Bupropion—Somnolence—Hydroxyurea—head and neck cancer	0.000607	0.00235	CcSEcCtD
Bupropion—Dyspepsia—Hydroxyurea—head and neck cancer	0.000601	0.00232	CcSEcCtD
Bupropion—Decreased appetite—Hydroxyurea—head and neck cancer	0.000594	0.0023	CcSEcCtD
Bupropion—Pancytopenia—Docetaxel—head and neck cancer	0.000593	0.00229	CcSEcCtD
Bupropion—Abdominal pain—Vinblastine—head and neck cancer	0.000592	0.00229	CcSEcCtD
Bupropion—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00059	0.00228	CcSEcCtD
Bupropion—Fatigue—Hydroxyurea—head and neck cancer	0.000589	0.00228	CcSEcCtD
Bupropion—Pain—Hydroxyurea—head and neck cancer	0.000584	0.00226	CcSEcCtD
Bupropion—Constipation—Hydroxyurea—head and neck cancer	0.000584	0.00226	CcSEcCtD
Bupropion—Weight increased—Docetaxel—head and neck cancer	0.000568	0.0022	CcSEcCtD
Bupropion—Vision blurred—Fluorouracil—head and neck cancer	0.000568	0.00219	CcSEcCtD
Bupropion—Weight decreased—Docetaxel—head and neck cancer	0.000564	0.00218	CcSEcCtD
Bupropion—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000563	0.00218	CcSEcCtD
Bupropion—Pneumonia—Docetaxel—head and neck cancer	0.00056	0.00216	CcSEcCtD
Bupropion—Anaemia—Fluorouracil—head and neck cancer	0.000557	0.00215	CcSEcCtD
Bupropion—Infestation—Docetaxel—head and neck cancer	0.000556	0.00215	CcSEcCtD
Bupropion—Infestation NOS—Docetaxel—head and neck cancer	0.000556	0.00215	CcSEcCtD
Bupropion—Hypersensitivity—Vinblastine—head and neck cancer	0.000552	0.00213	CcSEcCtD
Bupropion—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000552	0.00213	CcSEcCtD
Bupropion—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000548	0.00212	CcSEcCtD
Bupropion—Myocardial infarction—Docetaxel—head and neck cancer	0.000545	0.00211	CcSEcCtD
Bupropion—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000545	0.00211	CcSEcCtD
Bupropion—Stomatitis—Docetaxel—head and neck cancer	0.000542	0.0021	CcSEcCtD
Bupropion—Jaundice—Docetaxel—head and neck cancer	0.000542	0.0021	CcSEcCtD
Bupropion—Conjunctivitis—Docetaxel—head and neck cancer	0.000541	0.00209	CcSEcCtD
Bupropion—Body temperature increased—Hydroxyurea—head and neck cancer	0.00054	0.00209	CcSEcCtD
Bupropion—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.00054	0.0102	CbGpPWpGaD
Bupropion—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000539	0.0102	CbGpPWpGaD
Bupropion—Leukopenia—Fluorouracil—head and neck cancer	0.000539	0.00208	CcSEcCtD
Bupropion—Asthenia—Vinblastine—head and neck cancer	0.000537	0.00208	CcSEcCtD
Bupropion—CYP2C8—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000529	0.01	CbGpPWpGaD
Bupropion—Epistaxis—Docetaxel—head and neck cancer	0.000525	0.00203	CcSEcCtD
Bupropion—Convulsion—Fluorouracil—head and neck cancer	0.000522	0.00202	CcSEcCtD
Bupropion—Chest pain—Fluorouracil—head and neck cancer	0.000513	0.00198	CcSEcCtD
Bupropion—Myalgia—Fluorouracil—head and neck cancer	0.000513	0.00198	CcSEcCtD
Bupropion—Diarrhoea—Vinblastine—head and neck cancer	0.000512	0.00198	CcSEcCtD
Bupropion—Discomfort—Fluorouracil—head and neck cancer	0.000507	0.00196	CcSEcCtD
Bupropion—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000503	0.00195	CcSEcCtD
Bupropion—Haemoglobin—Docetaxel—head and neck cancer	0.000502	0.00194	CcSEcCtD
Bupropion—Rhinitis—Docetaxel—head and neck cancer	0.000501	0.00194	CcSEcCtD
Bupropion—Haemorrhage—Docetaxel—head and neck cancer	0.000499	0.00193	CcSEcCtD
Bupropion—Hepatitis—Docetaxel—head and neck cancer	0.000499	0.00193	CcSEcCtD
Bupropion—Hypoaesthesia—Docetaxel—head and neck cancer	0.000497	0.00192	CcSEcCtD
Bupropion—Confusional state—Fluorouracil—head and neck cancer	0.000496	0.00192	CcSEcCtD
Bupropion—Pharyngitis—Docetaxel—head and neck cancer	0.000496	0.00192	CcSEcCtD
Bupropion—Dizziness—Vinblastine—head and neck cancer	0.000495	0.00191	CcSEcCtD
Bupropion—Urinary tract disorder—Docetaxel—head and neck cancer	0.000493	0.00191	CcSEcCtD
Bupropion—Oedema peripheral—Docetaxel—head and neck cancer	0.000492	0.0019	CcSEcCtD
Bupropion—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000492	0.0019	CcSEcCtD
Bupropion—Oedema—Fluorouracil—head and neck cancer	0.000492	0.0019	CcSEcCtD
Bupropion—Connective tissue disorder—Docetaxel—head and neck cancer	0.000491	0.0019	CcSEcCtD
Bupropion—Asthenia—Hydroxyurea—head and neck cancer	0.00049	0.00189	CcSEcCtD
Bupropion—Urethral disorder—Docetaxel—head and neck cancer	0.00049	0.00189	CcSEcCtD
Bupropion—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000488	0.00926	CbGpPWpGaD
Bupropion—Infection—Fluorouracil—head and neck cancer	0.000488	0.00189	CcSEcCtD
Bupropion—Nervous system disorder—Fluorouracil—head and neck cancer	0.000482	0.00186	CcSEcCtD
Bupropion—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000481	0.00186	CcSEcCtD
Bupropion—Visual impairment—Docetaxel—head and neck cancer	0.000481	0.00186	CcSEcCtD
Bupropion—Tachycardia—Fluorouracil—head and neck cancer	0.00048	0.00186	CcSEcCtD
Bupropion—Vomiting—Vinblastine—head and neck cancer	0.000476	0.00184	CcSEcCtD
Bupropion—Erythema multiforme—Docetaxel—head and neck cancer	0.000472	0.00183	CcSEcCtD
Bupropion—Headache—Vinblastine—head and neck cancer	0.000469	0.00181	CcSEcCtD
Bupropion—Anorexia—Fluorouracil—head and neck cancer	0.000469	0.00181	CcSEcCtD
Bupropion—Diarrhoea—Hydroxyurea—head and neck cancer	0.000467	0.00181	CcSEcCtD
Bupropion—Eye disorder—Docetaxel—head and neck cancer	0.000467	0.0018	CcSEcCtD
Bupropion—Flushing—Docetaxel—head and neck cancer	0.000464	0.00179	CcSEcCtD
Bupropion—Cardiac disorder—Docetaxel—head and neck cancer	0.000464	0.00179	CcSEcCtD
Bupropion—Hypotension—Fluorouracil—head and neck cancer	0.000459	0.00178	CcSEcCtD
Bupropion—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000457	0.00866	CbGpPWpGaD
Bupropion—Angiopathy—Docetaxel—head and neck cancer	0.000453	0.00175	CcSEcCtD
Bupropion—Dizziness—Hydroxyurea—head and neck cancer	0.000452	0.00175	CcSEcCtD
Bupropion—CYP2D6—Xenobiotics—CYP1A1—head and neck cancer	0.000451	0.00855	CbGpPWpGaD
Bupropion—Immune system disorder—Docetaxel—head and neck cancer	0.000451	0.00174	CcSEcCtD
Bupropion—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—head and neck cancer	0.000451	0.00854	CbGpPWpGaD
Bupropion—Mediastinal disorder—Docetaxel—head and neck cancer	0.00045	0.00174	CcSEcCtD
Bupropion—Chills—Docetaxel—head and neck cancer	0.000448	0.00173	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000448	0.00173	CcSEcCtD
Bupropion—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.000447	0.00848	CbGpPWpGaD
Bupropion—Arrhythmia—Docetaxel—head and neck cancer	0.000446	0.00172	CcSEcCtD
Bupropion—Nausea—Vinblastine—head and neck cancer	0.000445	0.00172	CcSEcCtD
Bupropion—Insomnia—Fluorouracil—head and neck cancer	0.000445	0.00172	CcSEcCtD
Bupropion—Paraesthesia—Fluorouracil—head and neck cancer	0.000441	0.00171	CcSEcCtD
Bupropion—Alopecia—Docetaxel—head and neck cancer	0.000441	0.00171	CcSEcCtD
Bupropion—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.000439	0.00832	CbGpPWpGaD
Bupropion—Dyspnoea—Fluorouracil—head and neck cancer	0.000438	0.00169	CcSEcCtD
Bupropion—Mental disorder—Docetaxel—head and neck cancer	0.000438	0.00169	CcSEcCtD
Bupropion—Somnolence—Fluorouracil—head and neck cancer	0.000437	0.00169	CcSEcCtD
Bupropion—Malnutrition—Docetaxel—head and neck cancer	0.000435	0.00168	CcSEcCtD
Bupropion—Vomiting—Hydroxyurea—head and neck cancer	0.000434	0.00168	CcSEcCtD
Bupropion—CYP2D6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000434	0.00823	CbGpPWpGaD
Bupropion—Dyspepsia—Fluorouracil—head and neck cancer	0.000433	0.00167	CcSEcCtD
Bupropion—Rash—Hydroxyurea—head and neck cancer	0.000431	0.00166	CcSEcCtD
Bupropion—Dermatitis—Hydroxyurea—head and neck cancer	0.00043	0.00166	CcSEcCtD
Bupropion—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00043	0.00816	CbGpPWpGaD
Bupropion—Headache—Hydroxyurea—head and neck cancer	0.000428	0.00165	CcSEcCtD
Bupropion—Decreased appetite—Fluorouracil—head and neck cancer	0.000427	0.00165	CcSEcCtD
Bupropion—Dysgeusia—Docetaxel—head and neck cancer	0.000426	0.00165	CcSEcCtD
Bupropion—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000424	0.00164	CcSEcCtD
Bupropion—Back pain—Docetaxel—head and neck cancer	0.000421	0.00163	CcSEcCtD
Bupropion—Pain—Fluorouracil—head and neck cancer	0.00042	0.00163	CcSEcCtD
Bupropion—Muscle spasms—Docetaxel—head and neck cancer	0.000418	0.00162	CcSEcCtD
Bupropion—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.000416	0.00788	CbGpPWpGaD
Bupropion—Nausea—Hydroxyurea—head and neck cancer	0.000406	0.00157	CcSEcCtD
Bupropion—Feeling abnormal—Fluorouracil—head and neck cancer	0.000405	0.00157	CcSEcCtD
Bupropion—SLC6A2—NRF2 pathway—TGFA—head and neck cancer	0.000403	0.00763	CbGpPWpGaD
Bupropion—Anaemia—Docetaxel—head and neck cancer	0.000402	0.00155	CcSEcCtD
Bupropion—Urticaria—Fluorouracil—head and neck cancer	0.000391	0.00151	CcSEcCtD
Bupropion—Syncope—Docetaxel—head and neck cancer	0.00039	0.00151	CcSEcCtD
Bupropion—Leukopenia—Docetaxel—head and neck cancer	0.000389	0.0015	CcSEcCtD
Bupropion—Body temperature increased—Fluorouracil—head and neck cancer	0.000389	0.0015	CcSEcCtD
Bupropion—Palpitations—Docetaxel—head and neck cancer	0.000384	0.00149	CcSEcCtD
Bupropion—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.000382	0.00725	CbGpPWpGaD
Bupropion—Loss of consciousness—Docetaxel—head and neck cancer	0.000382	0.00148	CcSEcCtD
Bupropion—Cough—Docetaxel—head and neck cancer	0.000379	0.00147	CcSEcCtD
Bupropion—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000377	0.00715	CbGpPWpGaD
Bupropion—Convulsion—Docetaxel—head and neck cancer	0.000377	0.00146	CcSEcCtD
Bupropion—Hypertension—Docetaxel—head and neck cancer	0.000375	0.00145	CcSEcCtD
Bupropion—Chest pain—Docetaxel—head and neck cancer	0.00037	0.00143	CcSEcCtD
Bupropion—Arthralgia—Docetaxel—head and neck cancer	0.00037	0.00143	CcSEcCtD
Bupropion—Myalgia—Docetaxel—head and neck cancer	0.00037	0.00143	CcSEcCtD
Bupropion—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000368	0.00697	CbGpPWpGaD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000368	0.00142	CcSEcCtD
Bupropion—Hypersensitivity—Fluorouracil—head and neck cancer	0.000362	0.0014	CcSEcCtD
Bupropion—Dry mouth—Docetaxel—head and neck cancer	0.000362	0.0014	CcSEcCtD
Bupropion—Confusional state—Docetaxel—head and neck cancer	0.000358	0.00138	CcSEcCtD
Bupropion—SLC6A3—NRF2 pathway—TGFA—head and neck cancer	0.000357	0.00676	CbGpPWpGaD
Bupropion—Oedema—Docetaxel—head and neck cancer	0.000355	0.00137	CcSEcCtD
Bupropion—Anaphylactic shock—Docetaxel—head and neck cancer	0.000355	0.00137	CcSEcCtD
Bupropion—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000353	0.00669	CbGpPWpGaD
Bupropion—Infection—Docetaxel—head and neck cancer	0.000352	0.00136	CcSEcCtD
Bupropion—Shock—Docetaxel—head and neck cancer	0.000349	0.00135	CcSEcCtD
Bupropion—Nervous system disorder—Docetaxel—head and neck cancer	0.000348	0.00135	CcSEcCtD
Bupropion—Pruritus—Fluorouracil—head and neck cancer	0.000348	0.00134	CcSEcCtD
Bupropion—Thrombocytopenia—Docetaxel—head and neck cancer	0.000347	0.00134	CcSEcCtD
Bupropion—Tachycardia—Docetaxel—head and neck cancer	0.000346	0.00134	CcSEcCtD
Bupropion—Skin disorder—Docetaxel—head and neck cancer	0.000345	0.00133	CcSEcCtD
Bupropion—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000339	0.00642	CbGpPWpGaD
Bupropion—Anorexia—Docetaxel—head and neck cancer	0.000338	0.00131	CcSEcCtD
Bupropion—Diarrhoea—Fluorouracil—head and neck cancer	0.000336	0.0013	CcSEcCtD
Bupropion—CYP2D6—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000335	0.00635	CbGpPWpGaD
Bupropion—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000334	0.00633	CbGpPWpGaD
Bupropion—Hypotension—Docetaxel—head and neck cancer	0.000332	0.00128	CcSEcCtD
Bupropion—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00033	0.00625	CbGpPWpGaD
Bupropion—CYP2E1—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000327	0.00619	CbGpPWpGaD
Bupropion—Dizziness—Fluorouracil—head and neck cancer	0.000325	0.00126	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000323	0.00125	CcSEcCtD
Bupropion—SLC6A3—Dopaminergic Neurogenesis—STAT3—head and neck cancer	0.000323	0.00612	CbGpPWpGaD
Bupropion—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000321	0.00608	CbGpPWpGaD
Bupropion—Insomnia—Docetaxel—head and neck cancer	0.000321	0.00124	CcSEcCtD
Bupropion—Paraesthesia—Docetaxel—head and neck cancer	0.000319	0.00123	CcSEcCtD
Bupropion—Dyspnoea—Docetaxel—head and neck cancer	0.000316	0.00122	CcSEcCtD
Bupropion—Somnolence—Docetaxel—head and neck cancer	0.000315	0.00122	CcSEcCtD
Bupropion—Vomiting—Fluorouracil—head and neck cancer	0.000313	0.00121	CcSEcCtD
Bupropion—Dyspepsia—Docetaxel—head and neck cancer	0.000312	0.00121	CcSEcCtD
Bupropion—Rash—Fluorouracil—head and neck cancer	0.00031	0.0012	CcSEcCtD
Bupropion—Dermatitis—Fluorouracil—head and neck cancer	0.00031	0.0012	CcSEcCtD
Bupropion—Decreased appetite—Docetaxel—head and neck cancer	0.000308	0.00119	CcSEcCtD
Bupropion—Headache—Fluorouracil—head and neck cancer	0.000308	0.00119	CcSEcCtD
Bupropion—CYP2A6—Biological oxidations—NAT2—head and neck cancer	0.000307	0.00583	CbGpPWpGaD
Bupropion—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000306	0.00118	CcSEcCtD
Bupropion—Fatigue—Docetaxel—head and neck cancer	0.000306	0.00118	CcSEcCtD
Bupropion—Constipation—Docetaxel—head and neck cancer	0.000303	0.00117	CcSEcCtD
Bupropion—Pain—Docetaxel—head and neck cancer	0.000303	0.00117	CcSEcCtD
Bupropion—CYP2A6—NRF2 pathway—TGFA—head and neck cancer	0.000298	0.00565	CbGpPWpGaD
Bupropion—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000295	0.00559	CbGpPWpGaD
Bupropion—Feeling abnormal—Docetaxel—head and neck cancer	0.000292	0.00113	CcSEcCtD
Bupropion—Nausea—Fluorouracil—head and neck cancer	0.000292	0.00113	CcSEcCtD
Bupropion—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00029	0.00112	CcSEcCtD
Bupropion—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000284	0.00538	CbGpPWpGaD
Bupropion—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000284	0.00538	CbGpPWpGaD
Bupropion—Body temperature increased—Docetaxel—head and neck cancer	0.00028	0.00108	CcSEcCtD
Bupropion—Abdominal pain—Docetaxel—head and neck cancer	0.00028	0.00108	CcSEcCtD
Bupropion—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000271	0.00514	CbGpPWpGaD
Bupropion—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00027	0.00511	CbGpPWpGaD
Bupropion—CYP2C8—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000267	0.00506	CbGpPWpGaD
Bupropion—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000266	0.00504	CbGpPWpGaD
Bupropion—CYP2C8—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000264	0.00501	CbGpPWpGaD
Bupropion—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000264	0.00501	CbGpPWpGaD
Bupropion—Hypersensitivity—Docetaxel—head and neck cancer	0.000261	0.00101	CcSEcCtD
Bupropion—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000261	0.00494	CbGpPWpGaD
Bupropion—Asthenia—Docetaxel—head and neck cancer	0.000255	0.000984	CcSEcCtD
Bupropion—Pruritus—Docetaxel—head and neck cancer	0.000251	0.000971	CcSEcCtD
Bupropion—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.00025	0.00474	CbGpPWpGaD
Bupropion—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.00025	0.00473	CbGpPWpGaD
Bupropion—CYP2B6—Biological oxidations—NAT2—head and neck cancer	0.000248	0.0047	CbGpPWpGaD
Bupropion—CYP2B6—Metapathway biotransformation—NAT2—head and neck cancer	0.000245	0.00464	CbGpPWpGaD
Bupropion—CYP2E1—Biological oxidations—NAT2—head and neck cancer	0.000243	0.0046	CbGpPWpGaD
Bupropion—Diarrhoea—Docetaxel—head and neck cancer	0.000243	0.000939	CcSEcCtD
Bupropion—CYP2E1—Metapathway biotransformation—NAT2—head and neck cancer	0.00024	0.00454	CbGpPWpGaD
Bupropion—Dizziness—Docetaxel—head and neck cancer	0.000235	0.000907	CcSEcCtD
Bupropion—SLC6A2—NRF2 pathway—GSTM1—head and neck cancer	0.000234	0.00443	CbGpPWpGaD
Bupropion—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000228	0.00433	CbGpPWpGaD
Bupropion—Vomiting—Docetaxel—head and neck cancer	0.000226	0.000872	CcSEcCtD
Bupropion—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000225	0.00427	CbGpPWpGaD
Bupropion—Rash—Docetaxel—head and neck cancer	0.000224	0.000865	CcSEcCtD
Bupropion—Dermatitis—Docetaxel—head and neck cancer	0.000224	0.000864	CcSEcCtD
Bupropion—Headache—Docetaxel—head and neck cancer	0.000222	0.000859	CcSEcCtD
Bupropion—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000219	0.00414	CbGpPWpGaD
Bupropion—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000217	0.00412	CbGpPWpGaD
Bupropion—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000215	0.00407	CbGpPWpGaD
Bupropion—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000214	0.00406	CbGpPWpGaD
Bupropion—Nausea—Docetaxel—head and neck cancer	0.000211	0.000815	CcSEcCtD
Bupropion—CYP2C8—Biological oxidations—NAT2—head and neck cancer	0.00021	0.00398	CbGpPWpGaD
Bupropion—SLC6A3—NRF2 pathway—GSTM1—head and neck cancer	0.000207	0.00393	CbGpPWpGaD
Bupropion—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	0.000207	0.00392	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000196	0.00372	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000196	0.00372	CbGpPWpGaD
Bupropion—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000196	0.00372	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000192	0.00364	CbGpPWpGaD
Bupropion—CYP2A6—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000191	0.00362	CbGpPWpGaD
Bupropion—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000187	0.00355	CbGpPWpGaD
Bupropion—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000186	0.00352	CbGpPWpGaD
Bupropion—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000186	0.00352	CbGpPWpGaD
Bupropion—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000185	0.00351	CbGpPWpGaD
Bupropion—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000185	0.00351	CbGpPWpGaD
Bupropion—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000184	0.00348	CbGpPWpGaD
Bupropion—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000183	0.00348	CbGpPWpGaD
Bupropion—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000177	0.00336	CbGpPWpGaD
Bupropion—CYP2A6—NRF2 pathway—GSTM1—head and neck cancer	0.000173	0.00328	CbGpPWpGaD
Bupropion—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.000172	0.00327	CbGpPWpGaD
Bupropion—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000171	0.00324	CbGpPWpGaD
Bupropion—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.00017	0.00322	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00017	0.00322	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000168	0.00319	CbGpPWpGaD
Bupropion—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000159	0.00301	CbGpPWpGaD
Bupropion—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000157	0.00298	CbGpPWpGaD
Bupropion—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000157	0.00297	CbGpPWpGaD
Bupropion—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000152	0.00288	CbGpPWpGaD
Bupropion—CYP2A6—Biological oxidations—GSTM1—head and neck cancer	0.000152	0.00288	CbGpPWpGaD
Bupropion—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000152	0.00287	CbGpPWpGaD
Bupropion—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000151	0.00285	CbGpPWpGaD
Bupropion—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000146	0.00277	CbGpPWpGaD
Bupropion—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.000145	0.00276	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000144	0.00273	CbGpPWpGaD
Bupropion—CYP2A6—Biological oxidations—CYP1A1—head and neck cancer	0.000144	0.00273	CbGpPWpGaD
Bupropion—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000142	0.0027	CbGpPWpGaD
Bupropion—CHRNA3—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000133	0.00253	CbGpPWpGaD
Bupropion—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000129	0.00244	CbGpPWpGaD
Bupropion—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000128	0.00242	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—UROD—head and neck cancer	0.000127	0.0024	CbGpPWpGaD
Bupropion—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000123	0.00234	CbGpPWpGaD
Bupropion—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000123	0.00232	CbGpPWpGaD
Bupropion—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	0.000122	0.00232	CbGpPWpGaD
Bupropion—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000121	0.00229	CbGpPWpGaD
Bupropion—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000121	0.00229	CbGpPWpGaD
Bupropion—CYP2E1—Biological oxidations—GSTM1—head and neck cancer	0.00012	0.00227	CbGpPWpGaD
Bupropion—CYP2E1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000118	0.00224	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000117	0.00221	CbGpPWpGaD
Bupropion—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	0.000116	0.0022	CbGpPWpGaD
Bupropion—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000114	0.00217	CbGpPWpGaD
Bupropion—CYP2E1—Biological oxidations—CYP1A1—head and neck cancer	0.000114	0.00216	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000113	0.00214	CbGpPWpGaD
Bupropion—CYP2E1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000112	0.00213	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000111	0.00211	CbGpPWpGaD
Bupropion—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000109	0.00207	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000108	0.00205	CbGpPWpGaD
Bupropion—CHRNA3—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000107	0.00203	CbGpPWpGaD
Bupropion—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	0.000104	0.00197	CbGpPWpGaD
Bupropion—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	0.000102	0.00194	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—UROD—head and neck cancer	0.000102	0.00194	CbGpPWpGaD
Bupropion—CHRNA3—Neuronal System—MAPK1—head and neck cancer	0.000102	0.00193	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—UROD—head and neck cancer	0.0001	0.0019	CbGpPWpGaD
Bupropion—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	9.93e-05	0.00188	CbGpPWpGaD
Bupropion—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	9.83e-05	0.00186	CbGpPWpGaD
Bupropion—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	9.69e-05	0.00184	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	9.2e-05	0.00174	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—UROD—head and neck cancer	8.64e-05	0.00164	CbGpPWpGaD
Bupropion—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	8.51e-05	0.00161	CbGpPWpGaD
Bupropion—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	8.44e-05	0.0016	CbGpPWpGaD
Bupropion—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	8.39e-05	0.00159	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	8.32e-05	0.00158	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	8.28e-05	0.00157	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	8.28e-05	0.00157	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	8.28e-05	0.00157	CbGpPWpGaD
Bupropion—CHRNA3—Neuronal System—HRAS—head and neck cancer	8.19e-05	0.00155	CbGpPWpGaD
Bupropion—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	8.07e-05	0.00153	CbGpPWpGaD
Bupropion—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	8e-05	0.00152	CbGpPWpGaD
Bupropion—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	7.96e-05	0.00151	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	7.89e-05	0.0015	CbGpPWpGaD
Bupropion—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	7.21e-05	0.00137	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	7.11e-05	0.00135	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—UROD—head and neck cancer	7.1e-05	0.00135	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—UROD—head and neck cancer	7.04e-05	0.00133	CbGpPWpGaD
Bupropion—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	6.84e-05	0.0013	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	6.74e-05	0.00128	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	6.71e-05	0.00127	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	6.65e-05	0.00126	CbGpPWpGaD
Bupropion—SLC6A3—Transmission across Chemical Synapses—MAPK1—head and neck cancer	6.44e-05	0.00122	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—UROD—head and neck cancer	6.01e-05	0.00114	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	5.56e-05	0.00105	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	5.49e-05	0.00104	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.46e-05	0.00103	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	5.28e-05	0.001	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—NAT2—head and neck cancer	5.26e-05	0.000996	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	5.2e-05	0.000986	CbGpPWpGaD
Bupropion—SLC6A3—Transmission across Chemical Synapses—HRAS—head and neck cancer	5.17e-05	0.00098	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—MAPK1—head and neck cancer	4.93e-05	0.000935	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.66e-05	0.000884	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—UROD—head and neck cancer	4.64e-05	0.00088	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—DPYD—head and neck cancer	4.61e-05	0.000874	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—YAP1—head and neck cancer	4.37e-05	0.000829	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—NAT2—head and neck cancer	4.24e-05	0.000804	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—NAT2—head and neck cancer	4.15e-05	0.000787	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—HRAS—head and neck cancer	3.96e-05	0.000751	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.81e-05	0.000723	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.77e-05	0.000715	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—DPYD—head and neck cancer	3.72e-05	0.000705	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—DPYD—head and neck cancer	3.64e-05	0.00069	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—NAT2—head and neck cancer	3.59e-05	0.000681	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—YAP1—head and neck cancer	3.53e-05	0.000669	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—YAP1—head and neck cancer	3.46e-05	0.000655	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—DPYD—head and neck cancer	3.15e-05	0.000597	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.1e-05	0.000588	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.07e-05	0.000582	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—YAP1—head and neck cancer	2.99e-05	0.000566	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—NAT2—head and neck cancer	2.95e-05	0.000559	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—NAT2—head and neck cancer	2.92e-05	0.000554	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.65e-05	0.000503	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—TYMS—head and neck cancer	2.63e-05	0.000498	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.62e-05	0.000498	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—GSTM1—head and neck cancer	2.6e-05	0.000492	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—DPYD—head and neck cancer	2.58e-05	0.00049	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—DPYD—head and neck cancer	2.56e-05	0.000486	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—NAT2—head and neck cancer	2.5e-05	0.000473	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—GPX1—head and neck cancer	2.49e-05	0.000471	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CYP1A1—head and neck cancer	2.46e-05	0.000466	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—YAP1—head and neck cancer	2.45e-05	0.000465	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—YAP1—head and neck cancer	2.43e-05	0.000461	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.24e-05	0.000425	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—DPYD—head and neck cancer	2.19e-05	0.000415	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—TYMS—head and neck cancer	2.12e-05	0.000402	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—GSTM1—head and neck cancer	2.09e-05	0.000397	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—YAP1—head and neck cancer	2.08e-05	0.000394	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—TYMS—head and neck cancer	2.08e-05	0.000393	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—GSTM1—head and neck cancer	2.05e-05	0.000389	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—GPX1—head and neck cancer	2.01e-05	0.00038	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CYP1A1—head and neck cancer	1.99e-05	0.000376	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—GPX1—head and neck cancer	1.96e-05	0.000372	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.96e-05	0.000371	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CYP1A1—head and neck cancer	1.94e-05	0.000369	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—NAT2—head and neck cancer	1.93e-05	0.000365	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.83e-05	0.000346	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—TYMS—head and neck cancer	1.79e-05	0.00034	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—GSTM1—head and neck cancer	1.77e-05	0.000336	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—GPX1—head and neck cancer	1.7e-05	0.000322	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—DPYD—head and neck cancer	1.69e-05	0.00032	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CYP1A1—head and neck cancer	1.68e-05	0.000319	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—YAP1—head and neck cancer	1.6e-05	0.000304	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.59e-05	0.000302	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.56e-05	0.000296	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—TYMS—head and neck cancer	1.47e-05	0.000279	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PTGS2—head and neck cancer	1.46e-05	0.000277	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—TYMS—head and neck cancer	1.46e-05	0.000277	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—GSTM1—head and neck cancer	1.46e-05	0.000276	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—GSTM1—head and neck cancer	1.44e-05	0.000274	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—GPX1—head and neck cancer	1.39e-05	0.000264	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—GPX1—head and neck cancer	1.38e-05	0.000262	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.38e-05	0.000262	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.38e-05	0.000262	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.37e-05	0.000259	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.36e-05	0.000258	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PTEN—head and neck cancer	1.28e-05	0.000242	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—TYMS—head and neck cancer	1.25e-05	0.000236	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.23e-05	0.000234	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—GPX1—head and neck cancer	1.18e-05	0.000224	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PTGS2—head and neck cancer	1.18e-05	0.000224	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.17e-05	0.000222	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PTGS2—head and neck cancer	1.16e-05	0.000219	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.12e-05	0.000213	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PTEN—head and neck cancer	1.03e-05	0.000195	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PTEN—head and neck cancer	1.01e-05	0.000191	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PTGS2—head and neck cancer	1e-05	0.000189	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—TYMS—head and neck cancer	9.63e-06	0.000183	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.6e-06	0.000182	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—GSTM1—head and neck cancer	9.52e-06	0.00018	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—GPX1—head and neck cancer	9.11e-06	0.000173	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CYP1A1—head and neck cancer	9.02e-06	0.000171	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PIK3CA—head and neck cancer	9e-06	0.000171	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PTEN—head and neck cancer	8.72e-06	0.000165	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PTGS2—head and neck cancer	8.21e-06	0.000156	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PTGS2—head and neck cancer	8.13e-06	0.000154	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—AKT1—head and neck cancer	7.35e-06	0.000139	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PIK3CA—head and neck cancer	7.26e-06	0.000138	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PTEN—head and neck cancer	7.16e-06	0.000136	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PIK3CA—head and neck cancer	7.11e-06	0.000135	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PTEN—head and neck cancer	7.09e-06	0.000134	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PTGS2—head and neck cancer	6.95e-06	0.000132	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PIK3CA—head and neck cancer	6.15e-06	0.000117	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PTEN—head and neck cancer	6.06e-06	0.000115	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—AKT1—head and neck cancer	5.93e-06	0.000112	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—AKT1—head and neck cancer	5.81e-06	0.00011	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PTGS2—head and neck cancer	5.36e-06	0.000102	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PIK3CA—head and neck cancer	5.05e-06	9.57e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—AKT1—head and neck cancer	5.02e-06	9.52e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PIK3CA—head and neck cancer	5e-06	9.49e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PTEN—head and neck cancer	4.68e-06	8.87e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PIK3CA—head and neck cancer	4.28e-06	8.11e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—AKT1—head and neck cancer	4.12e-06	7.82e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—AKT1—head and neck cancer	4.09e-06	7.75e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—AKT1—head and neck cancer	3.49e-06	6.62e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PIK3CA—head and neck cancer	3.3e-06	6.26e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—AKT1—head and neck cancer	2.7e-06	5.11e-05	CbGpPWpGaD
